Literature DB >> 26019295

Shedding of TNF receptor 2 by effector CD8⁺ T cells by ADAM17 is important for regulating TNF-α availability during influenza infection.

Matthew P DeBerge1, Kenneth H Ely2, Peter F Wright2, Edward B Thorp2, Richard I Enelow2.   

Abstract

Elevated levels of solTNFR2 are observed in a variety of human pathophysiological conditions but regulation of TNFR2 levels during disease is not well understood. We found that solTNFR2 levels were increased following influenza infection or live-attenuated influenza virus challenge in mice and humans, respectively. As influenza-specific CD8(+) T cells up-regulated expression of TNFR2 after infection in mice, we hypothesized that CD8(+) T cells contributed, in part, to solTNFR2 production after influenza infection and were interested in the mechanisms by which CD8(+) T cells regulate TNFR2 shedding. Activation of these cells by TCR stimulation resulted in enhanced shedding of TNFR2 that required actin remodeling and lipid raft formation and was dependent on MAPK/ERK signaling. Furthermore, we identified ADAM17 as the protease responsible for TNFR2 shedding by CD8(+) T cells, with ADAM17 and TNFR2 required in "cis" for shedding to occur. We observed similar activation thresholds for TNF-α expression and TNFR2 shedding, suggesting that solTNFR2 functioned, in part, to regulate solTNF-α levels. Production of solTNFR2 by activated CD8(+) T cells reduced the availability of solTNF-α released by these cells, and TNFR2 blockade during influenza infection in mice enhanced the levels of solTNF-α, supporting this hypothesis. Taken together, this study identifies critical cellular mechanisms regulating TNFR2 shedding on CD8(+) T cells and demonstrates that TNFR2 contributes, in part, to the regulation of TNF-α levels during infection. © Society for Leukocyte Biology.

Entities:  

Keywords:  adaptive immunity; cytokine regulation; host response; viruses

Mesh:

Substances:

Year:  2015        PMID: 26019295      PMCID: PMC4763598          DOI: 10.1189/jlb.3A0914-432RR

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  43 in total

1.  Critical role of TNF receptor type-2 (p75) as a costimulator for IL-2 induction and T cell survival: a functional link to CD28.

Authors:  Edward Y Kim; Hung-Sia Teh
Journal:  J Immunol       Date:  2004-10-01       Impact factor: 5.422

2.  Lytic versus stimulatory synapse in cytotoxic T lymphocyte/target cell interaction: manifestation of a dual activation threshold.

Authors:  Mustapha Faroudi; Clemens Utzny; Mariolina Salio; Vincenzo Cerundolo; Martine Guiraud; Sabina Müller; Salvatore Valitutti
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-10       Impact factor: 11.205

Review 3.  Signalling pathways of the TNF superfamily: a double-edged sword.

Authors:  Bharat B Aggarwal
Journal:  Nat Rev Immunol       Date:  2003-09       Impact factor: 53.106

4.  TNF type 2 receptor (p75) lowers the threshold of T cell activation.

Authors:  E Y Kim; H S Teh
Journal:  J Immunol       Date:  2001-12-15       Impact factor: 5.422

5.  Symptom pathogenesis during acute influenza: interleukin-6 and other cytokine responses.

Authors:  L Kaiser; R S Fritz; S E Straus; L Gubareva; F G Hayden
Journal:  J Med Virol       Date:  2001-07       Impact factor: 2.327

6.  Histamine antagonizes tumor necrosis factor (TNF) signaling by stimulating TNF receptor shedding from the cell surface and Golgi storage pool.

Authors:  Jun Wang; Rafia S Al-Lamki; Hui Zhang; Nancy Kirkiles-Smith; Mary Lou Gaeta; Sathia Thiru; Jordan S Pober; John R Bradley
Journal:  J Biol Chem       Date:  2003-03-19       Impact factor: 5.157

7.  Regulation of TCR-mediated T cell activation by TNF-RII.

Authors:  Rosa Maria Aspalter; Martha Marianne Eibl; Hermann Maximilian Wolf
Journal:  J Leukoc Biol       Date:  2003-07-01       Impact factor: 4.962

8.  Extracellular signal-regulated kinase phosphorylates tumor necrosis factor alpha-converting enzyme at threonine 735: a potential role in regulated shedding.

Authors:  Elena Díaz-Rodríguez; Juan Carlos Montero; Azucena Esparís-Ogando; Laura Yuste; Atanasio Pandiella
Journal:  Mol Biol Cell       Date:  2002-06       Impact factor: 4.138

9.  Differential tumor necrosis factor receptor 2-mediated editing of virus-specific CD8+ effector T cells.

Authors:  Stephen J Turner; Nicole L La Gruta; John Stambas; Gabriela Diaz; Peter C Doherty
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-01       Impact factor: 11.205

10.  Depletion of cellular cholesterol and lipid rafts increases shedding of CD30.

Authors:  Bastian von Tresckow; Karl-Josef Kallen; Elke Pogge von Strandmann; Peter Borchmann; Hans Lange; Andreas Engert; Hinrich P Hansen
Journal:  J Immunol       Date:  2004-04-01       Impact factor: 5.422

View more
  14 in total

Review 1.  The TNF Receptor Superfamily in Co-stimulating and Co-inhibitory Responses.

Authors:  Lindsay K Ward-Kavanagh; Wai Wai Lin; John R Šedý; Carl F Ware
Journal:  Immunity       Date:  2016-05-17       Impact factor: 31.745

2.  MerTK Cleavage on Resident Cardiac Macrophages Compromises Repair After Myocardial Ischemia Reperfusion Injury.

Authors:  Matthew DeBerge; Xin Yi Yeap; Shirley Dehn; Shuang Zhang; Lubov Grigoryeva; Sol Misener; Daniel Procissi; Xin Zhou; Daniel C Lee; William A Muller; Xunrong Luo; Carla Rothlin; Ira Tabas; Edward B Thorp
Journal:  Circ Res       Date:  2017-08-29       Impact factor: 17.367

3.  Integrating longitudinal clinical laboratory tests with targeted proteomic and transcriptomic analyses reveal the landscape of host responses in COVID-19.

Authors:  Yun Tan; Wei Zhang; Zhaoqin Zhu; Niu Qiao; Yun Ling; Mingquan Guo; Tong Yin; Hai Fang; Xiaoguang Xu; Gang Lu; Peipei Zhang; Shuangshuang Yang; Ziyu Fu; Dongguo Liang; Yinyin Xie; Ruihong Zhang; Lu Jiang; Shuting Yu; Jing Lu; Fangying Jiang; Jian Chen; Chenlu Xiao; Shengyue Wang; Shuo Chen; Xiu-Wu Bian; Hongzhou Lu; Feng Liu; Saijuan Chen
Journal:  Cell Discov       Date:  2021-06-08       Impact factor: 10.849

4.  The role of ADAM17 in the T-cell response against bacterial pathogens.

Authors:  Moritz Andreas Link; Karsten Lücke; Joanna Schmid; Valéa Schumacher; Thomas Eden; Stefan Rose-John; Hans-Willi Mittrücker
Journal:  PLoS One       Date:  2017-09-06       Impact factor: 3.240

5.  Aberrant frequency of TNFR2+ Treg and related cytokines in patients with CIN and cervical cancer.

Authors:  Teng Zhang; Jun Jiao; Xinlin Jiao; Lu Zhao; Xinli Tian; Qing Zhang; Daoxin Ma; Baoxia Cui
Journal:  Oncotarget       Date:  2017-12-22

6.  Multiomic disease signatures converge to cytotoxic CD8 T cells in primary Sjögren's syndrome.

Authors:  Shinya Tasaki; Katsuya Suzuki; Ayumi Nishikawa; Yoshiaki Kassai; Maiko Takiguchi; Rina Kurisu; Yuumi Okuzono; Takahiro Miyazaki; Masaru Takeshita; Keiko Yoshimoto; Hidekata Yasuoka; Kunihiro Yamaoka; Kazuhiro Ikeura; Kazuyuki Tsunoda; Rimpei Morita; Akihiko Yoshimura; Hiroyoshi Toyoshiba; Tsutomu Takeuchi
Journal:  Ann Rheum Dis       Date:  2017-05-18       Impact factor: 19.103

7.  TNFRSF1B Gene Variants and Related Soluble TNFR2 Levels Impact Resilience in Alzheimer's Disease.

Authors:  Jagan A Pillai; Gurkan Bebek; Maria Khrestian; James Bena; Cornelia C Bergmann; William S Bush; James B Leverenz; Lynn M Bekris
Journal:  Front Aging Neurosci       Date:  2021-02-25       Impact factor: 5.750

Review 8.  Implications of ADAM17 activation for hyperglycaemia, obesity and type 2 diabetes.

Authors:  Jennifer Matthews; Sofia Villescas; Lakshini Herat; Markus Schlaich; Vance Matthews
Journal:  Biosci Rep       Date:  2021-05-28       Impact factor: 3.840

9.  ADAM Metalloproteinase Domain 17 Regulates Cholestasis-Associated Liver Injury and Sickness Behavior Development in Mice.

Authors:  Wagdi Almishri; Liam A Swain; Charlotte D'Mello; Tyson S Le; Stefan J Urbanski; Henry H Nguyen
Journal:  Front Immunol       Date:  2022-01-13       Impact factor: 7.561

10.  Anti-Tumor Necrosis Factor Receptor 2 Antibody Combined With Anti-PD-L1 Therapy Exerts Robust Antitumor Effects in Breast Cancer.

Authors:  Qiang Fu; Qian Shen; Jin Tong; Liu Huang; Yi Cheng; Wei Zhong
Journal:  Front Cell Dev Biol       Date:  2021-11-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.